SIRT1 and breast cancer: Overall, SIRT1 overexpression in breast cancer is associated with increased malignancy, resistance to oxidative stress, and poor clinical outcomes, positioning SIRT1 as a key modulator of redox signaling and therapeutic escape [88,96].